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Abstract: 40 
 The neocortex contains hundreds to thousands of distinct subtypes of precisely connected 41 
neurons, allowing it to perform remarkably complex tasks of high-level cognition. Callosal 42 
projection neurons (CPN) connect the cerebral hemispheres via the corpus callosum, integrating 43 
cortical information, and playing key roles in associative cognition. CPN are a strikingly diverse 44 
set of neuronal subpopulations, and development of this diversity requires precise control by a 45 
complex, interactive set of molecular effectors. We have identified that the transcriptional co-46 
regulator Cited2 regulates and refines two stages of CPN development. Cited2 is expressed 47 
broadly by progenitors in the E15.5 SVZ, during the peak of superficial layer CPN birth, with a 48 
progressive post-mitotic refinement in expression, becoming restricted to CPN of somatosensory 49 
cortex postnatally. We generated progenitor-stage and post-mitotic forebrain-specific Cited2 50 
conditional knockout (cKO) mice, using the Emx1-Cre and NEX-Cre mouse lines, respectively. 51 
We demonstrate that Cited2 functions in progenitors, but is not necessary post-mitotically, to 52 
regulate both 1) broad generation of layer II/III CPN, and 2) acquisition of precise area-specific 53 
molecular identity and axonal/ dendritic connectivity of somatosensory CPN. This novel CPN 54 
subtype- and area-specific control from progenitor action of Cited2 adds yet another layer of 55 
complexity to the multi-stage developmental regulation of neocortical development.   56 
 57 
Significance Statement: 58 
This study identifies Cited2 as a novel subtype- and area-specific control over 59 
development of distinct subpopulations within the broad population of callosal projection 60 
neurons (CPN), whose axons connect the two cerebral hemispheres via the corpus callosum 61 
(CC). Currently, how the remarkable diversity of CPN subtypes is specified, and how they 62 
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differentiate to form highly precise and specific circuits, is largely unknown. We identified that 63 
Cited2 functions within SVZ progenitors to both broadly regulate generation of superficial layer 64 
CPN throughout the neocortex, and to refine precise area-specific development and connectivity 65 
of somatosensory CPN. Gaining insight into molecular development and heterogeneity of CPN 66 
will advance understanding of both diverse functions of CPN, and the remarkable range of 67 
neurodevelopmental deficits correlated with CPN/CC development. 68 
69 
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Introduction: 70 
 The neocortex contains hundreds to thousands of distinct neuronal subtypes that enable it 71 
to perform remarkably complex tasks. Callosal projection neurons (CPN) are the broad 72 
population of commissural neurons whose axons connect the two cerebral hemispheres via the 73 
corpus callosum (CC), the largest axonal tract in the mammalian brain. CPN are excitatory 74 
pyramidal projection neurons whose cell bodies reside in neocortical layers II/III (~80% in 75 
mouse), V (~20%), and a few % in VI (Catapano et al., 2001, Fame et al., 2011, Greig et al., 76 
2013), and play key, diverse roles in complex associative and integrative cognition. CPN are 77 
molecularly, morphologically, and functionally diverse between the four primary functional 78 
neocortical areas (Lomber et al., 1994, Olivares et al., 2001, Grove and Fukuchi-Shimogori, 79 
2003, Benavides-Piccione et al., 2006, O'Leary et al., 2007). Further, subpopulations of CPN 80 
maintain other non-callosal projections to contra- or ipsilateral striatum, primary somatosensory 81 
cortex, or frontal areas (Wilson, 1987, Mitchell and Macklis, 2005, Fame et al., 2011). CPN are 82 
thus a strikingly heterogeneous set of neuronal subpopulations, requiring precise control over 83 
development of their distinct subpopulations by a complex and interactive set of molecular 84 
controls. 85 
 Currently, how the remarkable diversity of CPN subtypes and connectivity is specified, 86 
and how they differentiate to form highly precise and specific circuits, is largely unknown. We 87 
previously identified a combinatorially-expressed set of genes that both define CPN as a broad 88 
population, and identify novel subpopulations of CPN during development (Molyneaux et al., 89 
2009). Cited2 encodes a transcriptional co-regulator that is significantly enriched in CPN over 90 
other cortical projection neuron subpopulations, with particularly high expression at early stages 91 
of CPN development (Molyneaux et al., 2009). CITED2 functions as a transcriptional co-92 
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activator by interacting with CBP/p300 (Bhattacharya et al., 1999, Freedman et al., 2003), or as a 93 
transcriptional co-repressor by competing with transcription factors for binding to CBP/p300 94 
(Freedman et al., 2003, Lou et al., 2011). Cited2 is critical for proper development of multiple 95 
systems, including heart, lung, lens, placenta, and blood, in addition to neural tube closure 96 
(Bamforth et al., 2001, Barbera et al., 2002, Bamforth et al., 2004, Weninger et al., 2005, 97 
Withington et al., 2006, Chen et al., 2008, Xu et al., 2008, Chen et al., 2009, Kranc et al., 2009). 98 
Although Cited2 function has not been investigated in cortical development, in these other 99 
systems CITED2 interacts with or regulates transcription factors known to function critically in 100 
cortical specification and development, including LHX2 (Glenn and Maurer, 1999), PAX6 (Chen 101 
et al., 2008, Chen et al., 2009), and AP2γ (Bamforth et al., 2001).  102 
 Here, we demonstrate that Cited2 regulates and refines two stages of CPN development. 103 
Cited2 is expressed broadly by progenitors of the E15.5 SVZ, during the peak of superficial layer 104 
CPN birth, with a progressive post-mitotic refinement in expression to CPN of somatosensory 105 
cortex postnatally. We generated progenitor-stage and post-mitotic forebrain-specific Cited2 106 
conditional null (cKO) mice, using the Emx1-Cre and NEX-Cre mouse lines, respectively. In 107 
progenitor-stage cKO, we identify broad reduction of TBR2-positive progenitors at E15.5 across 108 
the neocortex, resulting postnatally in both reduced thickness of superficial layers and a highly 109 
area-specific reduction of layer II/III somatosensory neocortical length. Importantly, loss of 110 
Cited2 function does not disrupt the barrel field, resulting instead in an unprecedented 111 
misalignment of molecular areal identity between layer II/III and layer IV. Further, we identify 112 
area-specific disruption of dendritic complexity and precise axonal connectivity of 113 
somatosensory CPN. Cited2 is not required post-mitotically for these functions even though 114 
some processes, like arealization and dendritic arborization, are completed post-mitotically. 115 
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Taken together, our results demonstrate that Cited2 functions differently from previously 116 
described mechanisms to regulate two stages of precise CPN development, acting in neocortical 117 
progenitors to both broadly regulate generation of superficial layer CPN throughout the 118 
neocortex, and in an areally-restricted manner to refine the distinct identity and precise 119 
connectivity of somatosensory CPN. This novel subtype- and area-specific control from 120 
progenitor action adds yet another layer of complexity to the multi-stage development of the 121 
neocortex. 122 
 123 
Materials and Methods: 124 
 125 
Mice  126 
 C57Bl/6 wildtype mice were obtained from Charles River Laboratories (Wilmington, 127 
MA, USA) for retrograde labeling, Western blotting, and determining gene expression. Cited2 128 
conditional floxed mice (C2f) (Preis et al., 2006), Lmo4 conditional floxed mice (L4f) (Deng et 129 
al., 2010), and NEX-Cre (Goebbels et al., 2006) were previously described. Emx1-Cre mice were 130 
generated by (Guo et al., 2000) and obtained from The Jackson Laboratory (Bar Harbor, Maine, 131 
USA), strain number 005628. To avoid non-specific cre recombinase activity in oocytes 132 
(Hayashi et al., 2003), all conditional knockouts were generated by crossing fl females with fl; 133 
cre+ males, and no offspring from fl; cre+ dams were analyzed. The morning of the day of the 134 
appearance of the vaginal plug was defined as E0.5. The day of birth was designated P0. All 135 
animal procedures were approved by Massachusetts General Hospital and/or Harvard University 136 
IACUCs. 137 
 138 
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In Situ Hybridization and Histology 139 
Postnatal tissue was fixed overnight in 4% paraformaldehyde (PFA)/PBS at 4° C; for 140 
flatmount analysis, cortices were flattened and fixed three days in 4% PFA/PBS at 4° C. Fixed 141 
tissue was sectioned on a vibrating microtome for in situ hybridization. Embryonic tissue was 142 
flash frozen in 2-methyl butane, embedded in TBS, and cryosectioned. In situ hybridization was 143 
performed as previously described (Cederquist et al., 2013). The probes were synthesized as 144 
described in previous publications: Cited2 (Molyneaux, et al. 2009); Rorβ, ephrinA5 ((Allen 145 
Brain Atlas Resources, http://www.brain-map.org)); EphA7 (Mori, et al. 1995); Cadh8 (Joshi, et 146 
al. 2008). 147 
 148 
Immunocytochemistry and Western Blotting 149 
Brains were post-fixed overnight in 4% PFA/PBS at 4°C, then were sectioned on a 150 
VT1000S vibrating microtome (Leica Microsystems). Sections were incubated in primary 151 
antibody dilutions at 4°C overnight, and appropriate secondary antibodies were selected from the 152 
Molecular Probes Alexa series (Invitrogen, Carlsbad, CA). Antigen retrieval methods were 153 
required to expose antigens for some of the primary antibodies. Sections were incubated in 0.1M 154 
citric acid (pH=6.0) for 10 min. at 95-98°C.  Primary antibodies were used as follows: goat anti-155 
LMO4 (Santa Cruz Biotech SC-11122), rat anti-TBR2 (eBioscience 14-4875), rabbit anti-TBR2 156 
(Abcam ab23345), rabbit anti- PAX6 (Millipore Ab2237), goat anti-BHLHB5 (Santa Cruz 157 
Biotech SC-6045), goat anti-CUX1 (Santa Cruz Biotech SC-13024), mouse anti-PH3 (Abcam 158 
ab14955), rabbit anti-PH3 (Upstate 06-570), mouse anti- βIII Tubulin (TUJ1) (Covance mms-159 
435P), mouse anti-PCNA (Sigma WH0005111M2), rat anti-CTIP2 (Abcam ab18465), rabbit 160 
anti-Ki67 (Abcam ab15580), rabbit-anti RORβ (a generous gift from  the Stunnenberg lab), 161 
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rabbit anti-5HT (Immunostar 20080), mouse anti-MBP (Chemicon MAB387), and rabbit anti-162 
GFP (Invitrogen A-11122). Immunocytochemistry was performed as previously described 163 
(Cederquist et al., 2013). 164 
Immunoblotting was performed as previously described (Macdonald et al., 2010). 165 
Briefly, neocortical tissue was isolated, and protein homogenates were separated by 4-20% SDS–166 
PAGE, and transferred to nitrocellulose membrane (Bio-Rad Trans-Blot). Membranes were 167 
incubated for 12–20 hours at 4 °C in rabbit anti-CITED2 (Abcam ab108345) primary antibody 168 
diluted in in 2% milk/TBS, and developed with goat anti-rabbit HRP IgG (BioRad) diluted in 2% 169 
milk/TBS, and signals were detected with chemiluminescence (Pierce, Rockford, IL). 170 
 171 
Quantification of Neocortical Length and Thickness 172 
All length and thickness measurements were performed with images of matched sagittal 173 
50μm sections using ImageJ to trace the curvature of the neocortical surface. Areas were 174 
delineated using the noted marker gene expression. Deep layers (V-VI) were identified as those 175 
including cells expressing high levels of CTIP2 and deeper. Superficial layers (II-IV) were 176 
identified as those superficial to high level CTIP2 expression. p-values were calculated using the 177 
unpaired two-tailed Student’s T-Test using GraphPad Prism for Mac (GraphPad Software, San 178 
Diego California USA, www.graphpad.com). A robust regression outliers (ROUT) test 179 
(Q=0.5%) was performed for all data sets with an N equal to or less than 10 (Motulsky and 180 
Brown, 2006). No outliers were discovered. 181 
 182 
Golgi Staining and Dendritic Complexity Analysis 183 
P22 mouse brains were immersed in freshly prepared impregnation solution (FD Rapid 184 
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GolgiStain kit; FD Neurosciences), and processed according to the protocol provided by the 185 
company. Neurons were imaged, and then traced blinded to genotype. Dendritic complexity was 186 
quantified using Sholl analysis (Sholl, 1953) employing ImageJ (Rasband, W.S., ImageJ, U. S. 187 
National Institutes of Health, Bethesda, Maryland, USA) with the Sholl Analysis Plugin (v1.0) 188 
(Ghosh Lab, http://labs.biology.ucsd.edu/ghosh/software/). The following parameters were used 189 
for dendrite analysis: step= 10 μm, beginning radius= 20 μm, final radius= 200 μm. 190 
 191 
High Angular Resolution Diffusion Imaging (HARDI) and Tractography Reconstruction  192 
 Adult (9 week old) mouse brains were perfused and fixed for an additional week in 4% 193 
paraformaldehyde solution containing 1 mM gadolinium (Gd-DTPA) MRI contrast agent to 194 
reduce the T1 relaxation time while ensuring that enough T2 -weighted signal remained. Brains 195 
were then scanned on a 4.7T Bruker Biospec MR system. The pulse sequence used for HARDI 196 
acquisition was a 3D diffusion-weighted spin-echo echo-planar imaging (EPI) sequence (Tuch et 197 
al., 2003) with a spatial resolution of 175 × 175 × 175 µm, sixty diffusion-weighted 198 
measurements (high b-value 4,000 sec/mm2). Diffusion Toolkit and TrackVis 199 
(http://trackvis.org) were used to reconstruct and visualize tractography pathways that crossed 200 
the midline and passed through both the right and left neocortical hemispheres using an angle 201 
threshold of 45°. Tractography was initiated from each voxel within the brain mask, which limits 202 
the number of streamlines. Rather than use an FA threshold, brain mask volumes generated from 203 
Diffusion Toolkit were used to terminate tractography pathways, because brain abnormalities can 204 
result in low FA values that may potentially incorrectly terminate tractography tracing 205 
(Takahashi et al., 2010, Rosen et al., 2013, Song et al., 2015).  Streamline length was not limited 206 
in the analyses. The regions of interest and exclusion were manually drawn from the MRI. We 207 
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included all tracts that crossed the midline and passed through both the right and left neocortical 208 
hemispheres.  Any tract that passed through the anterior commissure was excluded, ensuring that 209 
other fiber pathways were not contributing to our analyses.  210 
 211 
Anterograde and Retrograde Axonal Labeling 212 
P6 pups were anesthetized by hypothermia, somatosensory neocortex was injected 213 
stereotaxically with a pulled glass micropipette (tip diameter 80-100μm), and cell bodies were 214 
infected with either AAV-eGFP (Maguire et al., 2013), or the beta subunit of cholera toxin 215 
(CTB) labeled with alexa dyes, respectively. Cells were labeled from this boundary area with 216 
four tightly clustered injection sites, each consisting of 5 injections of 4.6 nl each at a depth of 217 
250μm. Only brains with matched injections were included in the analysis.  Mice were 218 
transcardially perfused for analysis at 6 weeks, as outlined previously. 219 
Injection area and contralateral CPN projection spread were analyzed using ImageJ 220 
(Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA.) 221 
Fluorescence intensity was measured in a defined box across the injection in a sagittal section. 222 
Total pixels were binned in 100μm bins extending rostrally and caudally from the center of the 223 
injection. Fluorescence pixel intensity was calculated as a function of distance from the center of 224 
injection within superficial layers of both the injected hemisphere of neocortex and the matched 225 
contralateral region. p-values for each bin were calculated using the Bonferroni post-test on the 226 
unpaired two-tailed Student’s T-Test using GraphPad Prism for Mac. Axonal distribution was 227 
divided into 3 regions (anterior tail: -1400μm to -800μm; center: -700μm to 700μm, and 228 
posterior tail: 800μm to 1400μm) and two-way ANOVA analysis was performed for each 229 
regional distribution using GraphPad Prism for Mac (GraphPad Software, San Diego California 230 
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USA, www.graphpad.com). A robust regression outliers (ROUT) test (Q=0.5%) was performed 231 
for all data sets with an N equal to or less than 10 (Motulsky and Brown, 2006). No outliers were 232 
discovered. 233 
 234 
Cell Counts and Density Quantification 235 
E15.5 mouse neocortices were sectioned sagitally, imaged with confocal microscopy at 236 
three distinct rostro-caudal positions, and individual cells were quantified based on PAX6-, 237 
TBR2-, and PCNA-positivity. Change in basal cell divisions was evaluated by position of pH3-238 
positive mitotic cells. p-values were calculated using the Student’s t-test. Neocortical cellular 239 
density at P3 was measured in matched sagittal 14 μm cryosections stained for DAPI to mark 240 
nuclei, and immunolabeled for LMO4 and CTIP2 to mark areas and laminae. Boxes of standard 241 
width were digitally placed over images, and volume was calculated using 14 μm section 242 
thickness, measured orthogonal laminar thickness for each sample, and the 280 μm wide box; 243 
density is expressed as cells/100 μm3. p-values were calculated using the unpaired two-tailed 244 
Student’s t-test. A robust regression outliers (ROUT) test (Q=0.5%) was performed for all data 245 
sets with an N equal to or less than 10 (Motulsky and Brown, 2006). No outliers were 246 
discovered. 247 
 248 
Microscopy and Image Analysis 249 
Tissue sections were imaged on a Nikon 90i microscope using a 1.5 megapixel cooled 250 
CCD digital camera (Andor Technology, Dublin, Northern Ireland), or a 5 megapixel color CCD 251 
digital camera (Nikon Instruments, Melville, NY). Images were collected and analyzed with 252 
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Elements acquisition software (Nikon Instruments, Melville, NY). Laser confocal analysis was 253 
performed using a BioRad Radiance 2100 confocal microscope with LaserSharp2000 imaging 254 
software (BioRad Laboratories, Hercules, CA). Images were processed using a combination of 255 
functions provided by Elements analysis software (Nikon Instruments, Melville, NY), ImageJ 256 
(Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA), and 257 
Adobe Photoshop/ Illustrator software packages (Adobe, San Jose, CA). 258 
 259 
 260 
 261 
 262 
 263 
Results: 264 
Cited2 is expressed in the SVZ at E15.5 and, postnatally, by a restricted population of 265 
somatosensory CPN  266 
The transcriptional co-regulator Cited2 (CBP/p300-interacting transactivator with 267 
glutamic acid (E)/aspartic acid (D)-rich C-terminal domain 2) is more highly expressed by CPN 268 
relative to other cortical projection neuron subpopulations (in particular, corticospinal motor 269 
neurons, CSMN) in the developing neocortex, with peak differential expression at E18.5, the 270 
earliest time point at which CPN and CSMN can be purified by retrograde labeling (Molyneaux 271 
et al., 2009) (Figure 1A). We confirmed and more broadly investigated the neocortical 272 
expression of CITED2 protein by Western blotting from the developing neocortex, revealing 273 
high CITED2 expression beginning at E15.5, and decreasing postnatally (Figure 1B). In situ 274 
hybridization reveals that there is minimal pallial expression of Cited2 at E13.5, but Cited2 is 275 
  13
highly expressed in progenitor regions throughout the subventricular zone (SVZ) of developing 276 
neocortex during superficial layer CPN generation at E15.5 (Figure 1C,D), with expression 277 
decreasing as differentiation proceeds. Postnatally, total expression levels of Cited2 decrease, 278 
and its neocortical expression strikingly refines to layers II/III, V, and VI of somatosensory 279 
areas, mirroring the laminar distribution of CPN (Figure 1E,F). To further investigate this 280 
refinement of Cited2 expression, we examined Cited2 expression in sagittal preparations (Figure 281 
1G-H). Embryonically, Cited2 is expressed across the rostro-caudal extent of the neocortex 282 
(Figure 1G). Postnatally, Cited2 expression becomes progressively restricted to CPN (in layers 283 
II/III, V, and VI) of somatosensory neocortex by P3, in keeping with the known refinement of 284 
molecular areal boundaries (Figure 1H). This broad early SVZ progenitor expression across 285 
areas, with postnatal areal refinement to somatosensory CPN, led us to hypothesize two stages of 286 
function for Cited2 in neocortical, and specifically CPN, development: broadly in generation of 287 
superficial layers, and area-specifically in maturation of somatosensory CPN.  288 
The SVZ is largely composed of intermediate progenitor cells (IPCs; or basal 289 
progenitors), which are transit amplifying progenitors that arise from asymmetric divisions of 290 
radial glial cells (RGCs) of the VZ, and which undergo a limited number of symmetric divisions 291 
before generating pairs of post-mitotic neurons (Haubensak et al., 2004, Miyata et al., 2004, 292 
Noctor et al., 2004). Although IPCs give rise to projection neurons of all laminae, at E15.5, the 293 
peak of Cited2 expression, they largely generate superficial layer projection neurons (Sessa et al., 294 
2008, Kowalczyk et al., 2009), of which CPN are the predominant population. The high Cited2 295 
expression throughout the SVZ suggests a potential Cited2 function in IPCs at E15.5. At E15.5, 296 
Cited2 is most highly expressed in the laminar domain that overlaps with TBR2-expressing 297 
(TBR2+) IPCs of the SVZ, extending into the early post-mitotic neurons of the intermediate 298 
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zone, but it is mostly excluded from the region containing PAX6+ RGCs of the VZ (Figure 1I, 299 
J). The SVZ region expressing Cited2 includes both proliferating and non-proliferating 300 
populations, as assessed by the mitotic markers Ki67 and phosphorylated histone H3 (pH3) 301 
(Figure 1I, K). Taken together, these data suggest that CITED2 functions in SVZ IPCs as they 302 
transition from cycling progenitors to post-mitotic neurons across all areal anlagen at E15.5, 303 
when superficial neocortical neurons are being generated. 304 
 305 
Cited2 controls TBR2+ IPC number and proliferation in E15.5 neocortex 306 
To investigate developmental requirements for Cited2 in neocortical generation and 307 
precise CPN maturation, we generated mice null for Cited2 in the neocortex. To bypass a set of 308 
early patterning defects in homozygous Cited2 null mutants (Bamforth et al., 2001), and any 309 
confounding role Cited2 might have in the subpallial domain, we generated pallial cortex-310 
specific conditional knockouts using Emx1-promoter driven cre-recombinase (Emx1-Cre) (Guo 311 
et al., 2000, Jin et al., 2000). In all experiments, we compared Cited2fl/fl; Emx1-Cre+ conditional 312 
knockout mice (cKO) to littermate controls, both Cited2 fl/fl; Emx1-Cre-, and Cited2fl/+; Emx1-313 
Cre+. Because no significant differences were observed between the two control genotypes, they 314 
were combined as Cited2 WT in analyses. We verified that these cKO mutants are viable and 315 
healthy, and confirmed that early cortical neurogenesis, preceding onset of pallial Cited2 316 
expression, is not affected in Cited2 cKO brains, as assessed by VZ (Cited2 WT = 2694±36μm, 317 
Cited2 cKO = 2683±56μm; N = 10 WT and 5 cKO, p = 0.87) and cortical plate length (Cited2 318 
WT = 3163±33μm, Cited2 cKO = 3093±75μm; p = 0.33) and thickness at E15.5 across the 319 
rostro-caudal axis (medial: Cited2 WT = 317±6μm, Cited2 cKO = 297±12μm; p = 0.12). 320 
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Because Cited2 is highly expressed throughout the SVZ at E15.5, we specifically 321 
investigated whether the population of TBR2+ IPCs is altered in the absence of Cited2 function. 322 
In the setting of a broadly well-patterned and laminated E15.5 neocortex, there is a highly 323 
specific ~20% reduction of TBR2+ IPCs in Cited2 cKO mice (Figure 2B), while the number of 324 
PAX6+ RGCs is not altered (Figure 2A). At this age, only a small fraction of TBR2+ IPCs are 325 
actively proliferating, as assessed by PCNA; however, there is a significant decrease in the 326 
number of PCNA+ IPCs in Cited2 cKO mice (Figure 2C). The total number of PCNA+ cells, 327 
largely PAX6+ RGCs, is not altered in Cited2 cKO mice (Cited2 WT = 115±2 PCNA+ cells / 328 
100μm, Cited2 cKO = 113±2 PCNA+ cells / 100μm; N = 10 WT and 6 cKO, p = 0.67). We 329 
directly investigated the population of actively proliferating IPCs as basal mitotic pH3+ 330 
progenitors (Figure 2D). While there is not a general disruption in mitotic progenitors, there is a 331 
specific reduction in basally-located mitotic progenitors, indicating a specific requirement for 332 
Cited2 in IPC proliferation, but not that of RGC. 333 
In addition to perturbed proliferation, a reduction in TBR2+ IPCs might also result from 334 
cell death. We directly investigated this possibility by assessing apoptosis at E15.5 using 335 
activated caspase 3 (aC3+). We identified a significant increase in aC3+ cells in Cited2 cKO 336 
neocortex, both proliferating progenitors (PCNA+) and post-mitotic neurons (Figure 2E). This 337 
significant increase in apoptosis among progenitors likely contributes to the substantial decrease 338 
in TBR2+ progenitors in Cited2 cKO neocortex. 339 
The reduction in PCNA+/TBR2+ IPCs and basally-located mitotic progenitors in the 340 
Cited2 cKO neocortex suggests that Cited2 is necessary for expansion of the IPC population. To 341 
directly investigate whether Cited2 cell-autonomously regulates proliferation of IPCs, we 342 
electroporated Cre recombinase into progenitors of Cited2 fl/fl and Cited2 fl/wt littermates at E14.5, 343 
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to excise Cited2 in a small subpopulation of neocortical progenitors. We co-electroporated GFP 344 
to identify progenitors that were cycling at E14.5 and were electroporated, and we employed a 345 
BrdU pulse at E15.5 and immunocytochemistry for Ki67 at E16.5 to identify progenitors that 346 
continued to proliferate (Figure 2 F-F’’’). We identified a significant reduction both in the 347 
number of Cited2-null (Cited2 fl/fl; Cre+) progenitors that incorporated BrdU at E15.5 and in the 348 
number of Cited2-null (Cited2 fl/fl; Cre+) progenitors that were Ki67+ at E16.5. Further, there 349 
was a significant reduction in the number of cells proliferating at E15.5 that were still cycling at 350 
E16.5 (BrdU/Ki67 double-positive). Additionally, we employed immunocytochemistry for 351 
activated caspase 3 (aC3) at E16.5, and did not identify a significant change in the number of 352 
Cited2-null (Cited2 fl/fl; Cre+) progenitors that were dying at E16.5. These analyses demonstrate 353 
that Cited2-null IPCs are less likely to re-enter the cell cycle than their heterozygous 354 
counterparts, further supporting the conclusion that Cited2 cell-autonomously contributes to 355 
regulation of IPC proliferation, and that this reduction in basal progenitor proliferation 356 
contributes to the reduction in TBR2+ progenitors in Cited2 cKO neocortex at E15.5. 357 
The later areal refinement of Cited2 expression raises the hypothesis that CITED2 358 
function in the SVZ is areally restricted based on overlapping, intersectional expression of co-359 
regulators. For example, the known CITED2 interactor AP2γ (Bamforth et al., 2001) is broadly 360 
expressed across the ventricular zone; however, it regulates specification of TBR2+ IPCs and 361 
generation of superficial layers only in the occipital cortex (Pinto et al., 2009), presumably 362 
through an area-restricted co-regulator. To investigate whether Cited2 functions in an areally-363 
restricted manner within SVZ progenitors, we analyzed IPC numbers in three presumptive areal 364 
regions, and determined that the progenitor abnormality is uniform across the extent of the 365 
developing neocortex (Tbr2+ cells/100μm: rostral- WT = 76.7 ± 1.6, cKO = 61.7 ± 3.4, p = 366 
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0.0004; medial- WT = 69.5 ± 1.9, cKO = 52.2 ± 3.7, p = 0.0003; caudal- WT = 63.7 ± 2.9, cKO = 367 
47.3 ± 5.5, N = 10 WT and 6 cKO, p = 0.01 Student’s t-test;), indicating that the function of Cited2 368 
in IPC proliferation and survival is not areally restricted. 369 
 370 
Cited2 regulates neocortical size, including superficial layer thickness and neocortical surface 371 
length 372 
Superficial layer CPN arise predominantly from IPCs (Sessa et al., 2008, Kowalczyk et 373 
al., 2009); therefore, we investigated whether this significant, broad reduction of IPCs in the 374 
Cited2 null neocortex at E15.5 causes a reduction in superficial layer CPN, presenting as a 375 
change either radially in thickness of the superficial layers, and/or tangentially in the cortical 376 
length. Cited2 is not required for gross neocortical development or laminar organization. At 377 
postnatal day (P) 6, the Cited2 cKO neocortex is smaller than WT littermate controls, but both CPN 378 
(SATB2+) and CSMN (CTIP2+) are present and appropriately positioned (Figure 3A). Anterograde 379 
labeling with DiI, and retrograde labeling with fluorescently-conjugated Cholera toxin B (CTB), 380 
demonstrate that CPN are present and are appropriately targeting axons to the contralateral 381 
hemisphere in Cited2 cKO neocortex (Figure 3B, C). However, both the distribution of retrogradely-382 
labeled CPN (Figure 3C), and CUX1 and CTIP2 immunocytochemistry (Figure 3D), indicate that 383 
superficial layers are reduced in thickness in Cited2 cKO cortex, while deep layers are not changed in 384 
thickness. 385 
Quantitative analysis of neocortical layer thickness at P3 reveals a significant ~20% 386 
reduction in superficial layer thickness (layers II/III and IV, as delineated as cells superficial to 387 
CTIP2 expression) across multiple neocortical areas, including rostal motor cortex, the primary 388 
somatosensory area, and caudal visual cortex. There is no significant change in deep layer 389 
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thickness (layer V and VI) in any region, where CPN account for only a minority of projection 390 
neurons (Figure 3E). To directly investigate whether the reduced superficial layer thickness 391 
identified in Cited2 cKO neocortex is due to reduced cell number and/or increased cell packing, 392 
we quantified cell density within the reduced superficial layers. There is no significant difference 393 
in cell density in layers II/III of motor or visual cortices, and a modest, but significant, increase 394 
in cell density in layer II/III of somatosensory cortex, where the greatest reduction in thickness is 395 
observed (motor: Cited2 WT = 369±128 cells/100μm3, Cited2 cKO = 462±30 cells/100μm3; p = 396 
0.44; somatosensory: Cited2 WT = 652±66 cells/100μm3, Cited2 cKO = 803±26 cells/100μm3; p 397 
= 0.01; visual: Cited2 WT = 590±35 cells/100μm3, Cited2 cKO = =608±7 cells/100μm3; p = 398 
0.55; N = 6 WT and 3 cKO). Additionally, the reduction in superficial laminar thickness in 399 
Cited2 cKO neocortex persists at P6 (Figure 3D) and into adulthood. These data indicate that the 400 
reduction in the number of TBR2+ IPCs observed early in the development of Cited2 null 401 
neocortex results in a significant reduction in the number of superficial layer CPN throughout the 402 
neocortex. Interestingly, the findings regarding cell density indicate a further area-specific 403 
requirement for Cited2 in development of layer II/III neurons of somatosensory neocortex. 404 
 In addition to the observed reduction in radial thickness in Cited2 cKO neocortex, early 405 
loss of TBR2+ progenitors might also result in an overall decrease in neocortical length on the 406 
tangential axis (Sessa et al., 2008, Kowalczyk et al., 2009, Tuoc et al., 2013). We measured 407 
cortical surface length at P3, identifying an ~5% smaller diagonal cortical length, and an ~10% 408 
reduction in rostro-caudal neocortical surface length in P3 Cited2 cKO neocortex, measured 409 
across multiple medio-lateral sagittal sections (Figure 3F,G). These data indicate that there is 410 
both significant reduction in cortical thickness as a result of Cited2 loss of function, and 411 
significant reduction in neocortical tangential length. This reduction of cortical length does not 412 
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normalize over time; at P21, Cited2 cKO neocortex is still significantly shorter than that of WT 413 
littermates (Cited2 cKO normalized to Cited2 WT littermates = 90.9±3% neocortical length; p = 414 
0.005, N = 6 WT and 3 cKO), indicating that the reduction is not simply a delay in maturation, 415 
but, rather, a persistent reduction of ~10% of the neocortical rostro-caudal surface length. 416 
 417 
Cited2 refines the boundary of areal molecular identity of layer II/III somatosensory CPN 418 
Progressive post-mitotic refinement of Cited2 expression to somatosensory cortex led us 419 
to hypothesize that CITED2 might have a second phase of function in areal-specification of 420 
CPN. Dual functions of Cited2 have previously been identified in eye development, in which 421 
Cited2 acts upstream of Pax6 to regulate lens morphogenesis, and negatively regulates HIF-1 422 
signaling to regulate hyaloid vasculature formation (Chen et al., 2008). Therefore, we assessed 423 
whether specification and development of somatosensory CPN are specifically disrupted in 424 
Cited2 cKO neocortex, beyond the broad reduction in IPCs and superficial layer generation. 425 
First, we investigated whether all neocortical areas are uniformly reduced in Cited2 cKO 426 
neocortex, or whether the cortical length reduction is areally restricted. 427 
Strikingly, analysis based on three broad cortical areas distinguished by LMO4 428 
expression at P3 (Joshi et al., 2008) indicates that there is a highly specific and substantial 429 
(~35%) reduction in the rostro-caudal length of somatosensory cortex in Cited2 cKO, versus no 430 
significant change in motor or caudal cortex (Figure 4A-C). A similar reduction in 431 
somatosensory cortex is observed by expression of BHLHB5 (Figure 5F, H), which has a 432 
largely complementary expression to LMO4, and is highly expressed by CPN of somatosensory 433 
neocortex (Joshi et al., 2008, Cederquist et al., 2013). Thus, the entire 10% neocortical tangential 434 
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length reduction occurs in the somatosensory region in which Cited2 is normally expressed 435 
postnatally. 436 
Because Cited2 expression progressively refines to CPN of somatosensory cortex during 437 
the first postnatal days, we investigated when the area-specific function of Cited2 arises. At P0, 438 
before motor and somatosensory cortical areas are fully refined, there is a reduction in both 439 
motor and somatosensory cortical lengths, as delineated by LMO4 immunostaining (cKO 440 
relative length: mot = 0.89 ±  0.04, p = 0.037; SS = 0.83 ± 0.047, p = 0.018; vis = 0.99 ± 0.046, 441 
N = 6 WT and 3 cKO, p = 0.89, Student’s t-test). The reduction in Cited2 cKO cortical length 442 
progressively becomes restricted to somatosensory cortex by P3 (cKO relative length: mot = 0.94 443 
±  0.046, p = 0.13; SS = 0.64 ± 0.13, p = 0.0005; vis = 1.02 ± 0.029, N = 8 WT and 4 cKO, p = 444 
0.32, Student’s t-test) as wildtype expression of Cited2 becomes restricted to somatosensory 445 
cortex; this specificity for Cited2 function in somatosensory cortex is maintained at P8 (cKO 446 
relative length: SS = 0.73 ± 0.06; N = 10 WT and 5 cKO,  p<0.0001, Student’s t-test).   447 
We confirmed the somatosensory-specific reduction of cortical length in P3 Cited2 cKO 448 
mice using the expression of multiple overlapping and / or complementary molecular markers 449 
that, in combination, delineate cortical areas at P3 (Dye et al., 2011). Strikingly, layer II/III 450 
measurements of somatosensory cortex length by Cadh8, EphrinA5, and EphA7 expression 451 
confirm the reduced length observed with Lmo4 measurements (Figure 4D-F). Consistent with 452 
the CPN subtype-specific expression of Cited2, this areal-specific reduction is also layer specific, 453 
with no significant difference in length of acallosal layer IV, by expression of EphrinA5 and 454 
Rorβ in somatosensory cortex in Cited2 cKO mice (Figure 4F-G). In addition, loss of Cited2 455 
function does not disrupt somatosensory barrel morphology, size, or placement (data not shown).  456 
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These results indicate highly specific and significant disruption of layer II/III 457 
somatosensory cortex in the absence of Cited2 function. Taken together, these data suggest that 458 
Cited2 is selectively necessary for acquisition of molecular areal identity of layer II/III 459 
somatosensory CPN, but not generally for somatosensory neocortical arealization. In P3 WT 460 
neocortex, molecular markers of layer IV primary somatosensory cortex (e.g. Rorβ) and layer 461 
II/III somatosensory neocortex (e.g. BHLHB5) align to indicate the boundary between motor and 462 
somatosensory cortices (Figure 4H-H’’’). Notably, upon loss of Cited2 function, the rostral 463 
boundary of Rorβ expression is no longer aligned with BHLHB5 expression, (Figure 4I-I’’’), 464 
but, rather, extends further rostral than the molecularly-identified somatosensory region in layer 465 
II/III, indicating an unprecedented misalignment of molecular areal identity between layer II/III 466 
and layer IV in the Cited2 cKO. This neuronal subtype-specific areal misalignment could result 467 
in columnar wiring irregularities, the functional consequences of which would be intriguing to 468 
investigate in the future. 469 
 470 
Cited2 and Lmo4 cooperatively control CPN areal identity  471 
The above evidence indicates functions for Cited2 in specific acquisition of 472 
somatosensory CPN identity, leading to the hypothesis that Cited2 might act as part of a 473 
molecular network to generate neuronal areal identity; additional molecular controls might 474 
function in acquisition of other CPN areal identities, interacting with Cited2 at the boundaries to 475 
define these sub-populations. Lmo4 is a particularly compelling candidate to function in CPN of 476 
motor cortex, and to interact with Cited2 at the motor-somatosensory cortex boundary. Lmo4 has 477 
reciprocal areal expression in the neocortex compared with Cited2, and has been shown to have 478 
areally-restricted roles in neocortical projection neuron subtype identities and connectivity 479 
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(Kashani et al., 2006, Joshi et al., 2008, Lee et al., 2008, Azim et al., 2009, Huang et al., 2009, 480 
Cederquist et al., 2013). Cited2 interacts genetically with Lmo4, and Lmo4 can partially 481 
functionally compensate for Cited2 in thymus development (Michell et al., 2010). This 482 
knowledge led us to hypothesize that Lmo4 might be performing a parallel, areal-specific 483 
function in motor cortex CPN, intersecting with Cited2 in areal boundary regions. Its maintained 484 
expression in motor cortex might underlie some of the CPN areal differences observed with 485 
Cited2 loss-of-function.  486 
To test this hypothesis, we generated cortex-specific Lmo4/Cited2 double conditional 487 
knockout (dcKO) mice using Emx1-Cre recombinase. While LMO4 plays broader roles in 488 
defining neocortical areas and barrel cortex (Kashani et al., 2006, Huang et al., 2009, Cederquist 489 
et al., 2013), we focused our analyses on motor and somatosensory superficial layer CPN. 490 
Because the Lmo4 floxed line is maintained on a mixed (C57Bl/6 and S129S6) genetic 491 
background, we confirmed that Cited2 cKO on this background demonstrates the same radial and 492 
tangential reductions in neocortical size as identified on a pure C57Bl/6 background. In all 493 
analyses, we compared control (Emx1-Cre negative), Lmo4 cKO (Cited2+/+;Lmo4fl/fl;Emx1Cre/+), 494 
Cited2 cKO (Cited2fl/fl;Lmo4+/+;Emx1Cre/+), and double cKO (Cited2fl/fl;Lmo4fl/fl;Emx1Cre/+) 495 
littermates.  496 
We identified that the additional loss of Lmo4 function does not alter the laminar 497 
thickness reduction of Cited2 cKO motor or visual cortex, but does lead to an increase in 498 
superficial layer thickness in somatosensory cortex (Figure 5A-C). Further, additional loss of 499 
Lmo4 function does not alter the overall tangential neocortical surface length (Cited2 cKO = 500 
6204 ± 88μm, double cKO = 6453 ± 117 μm; N = 8 Cited2 cKO and 9 double cKO, p = 0.09), as 501 
predicted from the post-mitotic restricted expression of LMO4 (Azim et al., 2009, Cederquist et 502 
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al., 2013). Therefore, LMO4 and Cited2 do not genetically interact in the neocortex to control 503 
neocortical size. Additionally, mis-expression of Cited2 does not repress expression of Lmo4 in 504 
motor cortex, nor induce Lmo4 expression in somatosensory cortex (data not shown). Because 505 
LMO4 is not expressed in neocortical progenitor regions, the maintenance of the reduced 506 
neocortical size of Cited2 cKO cortex in Lmo4/Cited2 dcKO cortex suggests that the reduction in 507 
neocortical size in Cited2 cKO neocortex results from broad Cited2 function within the SVZ 508 
progenitors.  509 
Strikingly, Lmo4/Cited2 dcKO neocortex, while exhibiting the same reduction in overall 510 
length as Cited2 cKO cortex, has the same somatosensory cortex size as control, exhibiting 511 
neither reduction in somatosensory length as exhibited by Cited2 cKO, nor increase in 512 
somatosensory length as seen in Lmo4 cKO (Kashani et al., 2006, Huang et al., 2009) (Figure 513 
5D-H, schematized in Figure 5I-L). Importantly, the shifts in areal boundaries that occur with 514 
single and double loss of Cited2 and Lmo4 function are restricted to the motor-somatosensory 515 
boundary, with the length of the visual cortex remaining the same across all genotypes. In the 516 
context of reduced total neocortical length with loss of Cited2 function, additional loss of Lmo4 517 
function results in a rostral shift of the motor-somatosensory boundary (to restore somatosensory 518 
cortex length), and reduction in motor cortex length. Taken together, these data indicate that 519 
Cited2 and Lmo4 participate in a network of compensatory and opposing molecular controls over 520 
subtype and specific areal identity within superficial layer CPN of somatosensory and motor 521 
cortex. Loss of Lmo4 function can rescue the superficial layer CPN arealization phenotype found 522 
in Emx1-Cre driven Cited2 cKO neocortex. 523 
 524 
Cited2 is not required post-mitotically for CPN areal identity  525 
  24
Somatosensory-specific postnatal phenotypes of Cited2-null CPN might be dependent on 526 
progenitor function of Cited2, or they could be fully independent phenotypes, indicating a bi-527 
phasic function for Cited2 during CPN development. To investigate potential post-mitotic 528 
requirements for Cited2 in acquisition of superficial layer CPN areal identity, we generated mice 529 
null for Cited2 in early post-mitotic neocortical pyramidal neurons using NEX-promoter driven 530 
cre-recombinase (NEX-Cre). In this mouse line, Cre recombinase is expressed specifically in 531 
post-mitotic pyramidal neurons of the neocortex and is absent from progenitors, interneurons, 532 
oligodendroglia, and astrocytes (Goebbels et al., 2006). Using a highly sensitive cre recombinase 533 
reporter (adenovirus GFP), Goebbels, et al. (2006) report that a small number of proliferating 534 
cortical cells were observed at E15.5, indicating that there is a very small window of time, if any, 535 
between cell cycle exit and onset of NEX-cre expression. In Cited2;NEX-cre cKO mice, there is 536 
highly efficient expression of a β-gal reporter across the postnatal neocortex, indicating highly 537 
efficient Cited2 excision (data not shown).  538 
We find that post-mitotic loss of Cited2 function in the neocortex (with NEX-cre 539 
excision) does not overtly disrupt neocortical development or laminar organization (Figure 6A). 540 
Further, there is no reduction in neocortical surface length or laminar thickness in Cited2;NEX-541 
cre cKOs (Figure 6B-C’’), indicating that the reduction in superficial layer CPN observed in the 542 
postnatal Cited2; Emx1-cre cKO results entirely from Cited2 function in IPCs. We next 543 
investigated whether refinement of layer II/III somatosensory areal identity is disrupted 544 
following post-mitotic Cited2 loss-of-function, as it is following Emx1-mediated Cited2 excision. 545 
Interestingly, there is no disruption in somatosensory length in P3 Cited2; NEX-cre cKO 546 
neocortex (Figure 6D-E). Taken together, these results indicate that the reduction in acquisition 547 
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of layer II/III somatosensory areal identity results from Cited2 function in neocortical 548 
progenitors, and it is not a fully independent post-mitotic function of Cited2. 549 
 550 
Disruption of area-apecific CPN dendritic complexity following excision of Cited2 in 551 
progenitors 552 
Cited2 functions broadly in early IPCs to both regulate generation of neocortical 553 
superficial layer CPN broadly, and to control acquisition of somatosensory molecular areal 554 
identity by layer II/III somatosensory CPN specifically. Somatosensory CPN have unique 555 
connectivity features, both in their afferent and efferent connections (Innocenti and Price, 2005, 556 
Benavides-Piccione et al., 2006). We therefore directly investigated potential functions of Cited2 557 
in central properties of their specific connectivity that govern the unique functionality of 558 
somatosensory CPN. We first examined neuronal soma size across all lamina and areas of 559 
Cited2; Emx-cre cKOs to determine if Cited2 loss-of-function disrupts overall size or growth of 560 
cortical projection neurons. Using NeuN to mark neuronal somata, we found no change in 561 
neuronal soma size (average soma cross-sectional area) at P21 in either deep or superficial layers 562 
(Figure 7A). These results indicate that the reduced superficial layer thickness (Figure 3) is not 563 
due to decreased CPN soma size. 564 
We then investigated dendritic complexity of layer II/III CPN by Golgi staining and Sholl 565 
analysis in multiple neocortical areas (Figure 7). While there is no significant change in layer 566 
II/III CPN dendritic complexity within motor or visual cortex in the Cited2; Emx1-cre cKO 567 
mice, there is a significant increase in CPN dendritic complexity in somatosensory cortex 568 
(Figure 7B-D). In Cited2 WT neocortex, dendritic complexity of layer II/III CPN is distinct 569 
across different neocortical areas (Figure 7E), with decreasing complexity rostral to caudal, as 570 
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has been shown previously (Benavides-Piccione et al., 2006). Interestingly, there is a shift in 571 
total dendritic arbor distribution in Cited2; Emx1-cre cKO somatosensory cortex CPN to more 572 
closely resemble CPN in motor cortex, with more dendrites close to neuronal cell bodies (Figure 573 
7F). Taken together these results indicate that dendritic complexity is specifically increased in 574 
somatosensory CPN in Cited2; Emx1-cre cKO cortex, perhaps suggesting that Cited2-null CPN 575 
might be partially ‘motorized’ with respect to dendritic complexity. 576 
Because dendritic arborization occurs post-mitotically, we investigated whether dendritic 577 
development of somatosensory CPN is also perturbed following post-mitotic-specific Cited2 578 
loss-of-function, or whether it is dependent on the reduction in acquisition of layer II/III 579 
somatosensory areal identity that results from Cited2 function in neocortical progenitors. We 580 
find that NEX-cre mediated excision of Cited2 does not alter CPN soma size (data not shown) or 581 
CPN dendritic complexity in any area (Figure 7G-I). Together, these data indicate that 582 
continuous post-mitotic expression of Cited2 in somatosensory CPN is not required for 583 
development of areal subpopulation-appropriate CPN size and dendritic complexity; rather, 584 
alterations in CPN generation and areal identity acquisition arising from Cited2 function in 585 
progenitors disrupts development of somatosensory-specific CPN dendritic complexity.  586 
  587 
Cited2 is required for precise, homotopic CPN axonal connectivity 588 
In addition to area-specific dendritic complexity, we investigated potential Cited2 589 
function in CPN axonal connectivity, both broadly and in an area-specific manner. High-angular 590 
resolution diffusion imaging (HARDI) tractography based on magnetic resonance imaging 591 
(MRI) reveals that there are fewer correlated pathways passing throughout the corpus callosum 592 
(CC) of adult Cited2 cKO mouse brains as compared to control (Figure 8A-B), consistent with 593 
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the overall reduction in superficial layer thickness and CPN number. The reduced CC is 594 
confirmed by examining myelinated fibers in mid-sagittal sections labeled with myelin basic 595 
protein (MBP), revealing a significantly smaller CC area (Figure 8C-D). Overall forebrain and 596 
midbrain area is not reduced in Cited2 cKO mice, as measured on these mid-sagittal sections 597 
(WT = 38.6 ± 0.7 μm2, cKO = 37.0 ± 0.8 μm2; N = 3 WT, 4 cKO; p = 0.18), and Cited2 cKO CC 598 
area is reduced relative to brain area (p = 0.04). Neocortical area, on the other hand, is reduced in 599 
Cited2 cKO mice (WT = 11.5 ± 0.3 μm2, cKO = 10.1 ± 0.3 μm2; N = 3 WT, 4 cKO; p = 0.02), 600 
suggesting that the reduced CC area in Cited2 cKO mice results from the reduced number of 601 
CPN. Of particular note, HARDI reveals an apparent additional disruption in callosal fibers in 602 
mid-CC, even though the CC is overall present, but reduced, by MBP staining, suggesting 603 
localized axonal disorganization in addition to fewer fibers (Figure 8A’,B’).  604 
We directly investigated precision of CPN projections at the border between motor and 605 
somatosensory cortical areas, which is especially molecularly disrupted in Cited2; Emx1 cKO 606 
mouse cortex during development. Precisely matched, focal AAV-GFP anterograde labeling 607 
demonstrates that Cited2; Emx1 cKO somatosensory CPN project contralateral axons 608 
imprecisely, with a bimodal distribution of axonal projections covering a more expansive target 609 
area on the contralateral hemisphere than the tightly delineated homotopic areas targeted by WT 610 
CPN (Figures 8E-K). Taken together, these data indicate that Cited2 is required for precise 611 
areal-specific connectivity of somatosensory CPN, both afferent and efferent.  612 
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Discussion: 613 
CPN are a remarkably diverse set of neuronal subpopulations, requiring precise control 614 
over development of these subpopulations for proper organization and function. This study 615 
demonstrates that the transcriptional co-regulator CITED2 regulates two aspects of precise CPN 616 
development in mouse. Cited2 functions broadly in embryonic progenitors of the SVZ to 617 
regulate generation of superficial layer CPN throughout the neocortex. Cited2 also functions 618 
within progenitors to establish the distinct identity and development of somatosensory CPN, in 619 
an areally restricted manner. Understanding molecular controls over development of CPN 620 
subpopulations, such as CITED2 control over somatosensory layer II/III CPN, will advance 621 
understanding of diverse system functions of CPN, and the broad range of neurodevelopmental 622 
disorders with associated abnormalities of CPN / corpus callosum development – both overt and 623 
subtle.  624 
 625 
Cited2 regulates the precise number of TBR2+ IPCs generating layer II/III CPN 626 
 The SVZ has expanded concomitantly with the expansion of the cerebral cortex during 627 
mammalian evolution, suggesting that an increase in IPCs contributes substantially to the 628 
evolutionary expansion of the neocortex (Kriegstein et al., 2006, Martinez-Cerdeno et al., 2006, 629 
Molnar et al., 2006, Noctor et al., 2008, Betizeau et al., 2013). Disrupting the IPC population 630 
results in reduced cortical thickness of all layers, and reduced cortical surface area (Sessa et al., 631 
2008, Kowalczyk et al., 2009, Tuoc et al., 2013), with superficial layers most significantly 632 
impacted (Pontious et al., 2008). Expression of Cited2 in the SVZ peaks during generation of 633 
superficial layers, and loss of Cited2 function disrupts generation of superficial layers 634 
specifically. CUX2 similarly is expressed by IPCs only during late neurogenesis, and its loss 635 
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perturbs superficial layer neuron production specifically (Cubelos et al., 2008), further 636 
highlighting the increased molecular regulation, in which Cited2 has a substantial role, 637 
controlling the production of this set of neuronal populations. 638 
The reduction in Cited2; Emx1-cre cKO neocortical superficial layers arises from a 639 
significant reduction of TBR2+ IPCs at E15.5, the peak of superficial layer neuron birth. This 640 
reduction in TBR2+ IPCs likely results from both an increase in basal progenitor death, and a 641 
decrease in IPC proliferation /cell cycle re-entry. We identified an approximately 2-fold increase 642 
in cell death in Cited2 cKO neocortex, including both progenitors and post-mitotic cells. 643 
Increased apoptosis is also evident in the midbrain of Cited2-/- embryos during neural tube 644 
closure (Bamforth et al., 2001, Barbera et al., 2002), and CITED2 regulates death of cortical 645 
neurons in vitro after induced DNA damage (Gonzalez et al., 2008).  646 
In addition to increased apoptosis, there is a significant reduction in the number of 647 
proliferating IPCs at E15.5, and cell-autonomous Cited2 loss-of-function results in reduced cell 648 
cycle re-entry between E14.5 and E16.5, suggesting that Cited2 function is required to maintain 649 
and expand these transit-amplifying progenitors. In line with this interpretation, Cited2 is highly 650 
up-regulated by actively proliferating transit amplifying progenitors during induced regeneration 651 
in the olfactory epithelium (Shetty et al., 2005). Further, CITED2 controls proliferation in 652 
fibroblasts (Kranc et al., 2003), hematopoietic stem cells (Du and Yang, 2013), and non-small-653 
cell lung cancer cells (Chou et al., 2012). Taken together, the reduction in TBR2+ IPCs in E15.5 654 
Cited2 cKO SVZ is likely due, at least in large part, to reduced proliferation within this 655 
progenitor population, in addition to the identified apoptosis increase. 656 
 657 
Cited2 functions in concert with distinct transcriptional regulators  658 
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 Transcription factors that play roles in both areal and laminar identity have been 659 
identified. For example, TBR1 functions in post-mitotic neurons to regulate the appropriate 660 
differentiation of layer VI broadly, as well as the establishment of frontal cortex identity (Hevner 661 
et al., 2001, Bedogni et al., 2010), and PAX6 functions in progenitor cells to both regulate 662 
neurogenesis and promote rostral identity (Bishop et al., 2002, Schuurmans et al., 2004). The 663 
dual functions of Cited2 in CPN development appear to be quite different from these previously 664 
described mechanisms, however. Cited2 functions broadly in SVZ progenitors to regulate the 665 
generation of (primarily) layer II/III neurons; Cited2 also has a progenitor function leading to the 666 
acquisition of appropriate areal identity of a subpopulation of superficial layer CPN. Unlike areal 667 
identity genes, such as PAX6, Bhlhb5, and TBR1 (Joshi et al., 2008, Bedogni et al., 2010), loss 668 
of Cited2 function does not disrupt establishment of areal identity, per se. This is demonstrated 669 
by the apparently normal development of the barrel field, the hallmark of the primary 670 
somatosensory cortex, in the context of an areal disruption in somatosensory layer II/III. These 671 
results strongly suggest that CITED2 functions as part of a complex network of transcriptional 672 
co-regulators that interact, compete, and compensate to regulate and refine appropriate 673 
acquisition of areal identity within a particular projection neuron subpopulation, layer II/III CPN 674 
of somatosensory cortex.  675 
 We hypothesized that the transcriptional co-regulator LMO4 might function as part of 676 
this network, regulating the acquisition of areal identity of layer II/III CPN of motor cortex. We 677 
identified that additional removal of Lmo4 from Cited2 cKO neocortex results in a balanced 678 
reduction of molecularly defined motor and somatosensory areas within layer II/III, compared to 679 
the specific reduction in layer II/III somatosensory area with loss of Cited2 alone, and increase in 680 
layer II/III somatosensory area with loss of Lmo4 alone. Loss of Cited2 and Lmo4 function, 681 
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alone and in combination, does not result in complete loss of areal identity; rather, areal 682 
boundaries shift, highlighting that these transcriptional co-regulators provide a mutually 683 
dependent and partially antagonistic level of precise regulation of neuronal subtype-specific areal 684 
identity acquisition.  685 
 686 
Precise connectivity of somatosensory CPN 687 
Laminar composition and circuit organization is distinct within the primary 688 
somatosensory neocortex compared with other neocortical areas (Polleux et al., 2001, Rash and 689 
Grove, 2006, Dehay and Kennedy, 2007, O'Leary et al., 2007). The unique misalignment of layer 690 
II/III somatosensory neocortex relative to layer IV barrel cortex in Cited2 cKO neocortex likely 691 
profoundly perturbs this precise circuitry, as evidenced, in part, by the disrupted dendritic 692 
complexity and precise axonal connectivity of Cited2 cKO CPN. Dendritic complexity of layer 693 
II/III CPN is specific to each neocortical area in mice, with dendritic arbors becoming 694 
progressively more complex from caudal to rostral areas (Benavides-Piccione et al., 2006). CPN 695 
of Cited2-null somatosensory cortex display increased dendritic complexity that highly 696 
resembles that normally found in CPN of motor cortex. This is despite the fact that CPN from the 697 
motor / somatosensory border regions, where molecular boundaries are shifted during 698 
development, were excluded from this analysis. Layer II/III CPN that are within the molecularly 699 
defined somatosensory cortex (i.e. BHLHB5+/LMO4-) of Cited2 cKO mice develop dendritic 700 
morphology of CPN of normal motor cortex, indicating critical roles for Cited2 in somatosensory 701 
CPN afferent connectivity. 702 
Within young adult Cited2 cKO neocortex, CPN projections from the disrupted motor / 703 
somatosensory region are also quite imprecise, demonstrating a bimodal distribution of 704 
  32
projections rostro-caudally within somatosensory cortex. Further, high-angular resolution 705 
diffusion imaging (HARDI) identifies reduced callosal connectivity, particularly in mid-706 
callosum, correlating with somatosensory cortex. Normally, ectopic CPN projections are 707 
eliminated through activity-dependent mechanisms over the first postnatal weeks (Innocenti and 708 
Price, 2005, Luo and O'Leary, 2005, Mizuno et al., 2007, Wang et al., 2007, Zhou et al., 2013). 709 
The atypical projections identified in adult Cited2 cKO neocortex might be aberrantly 710 
maintained, and might indicate earlier disrupted neuronal activity of Cited2-null CPN during 711 
somatosensory cortex development. It has recently been shown that balanced thalamic input 712 
regulates targeting of callosal projections in somatosensory cortex (Suarez et al., 2014). Even 713 
though post-mitotic loss of Cited2 does not disrupt the metrics assessed here in somatosensory 714 
CPN, it would be of interest in future studies to assess whether Cited2 might be induced or 715 
maintained in post-mitotic somatosensory CPN in response to such balanced activity, leading to 716 
specific acquisition of other somatosensory CPN features. 717 
In humans, even subtle disruptions in callosal connectivity are associated with defects in 718 
abstract reasoning, problem solving, and generalization (Paul et al., 2007), as well as with 719 
multiple neurodevelopmental disorders, including autism spectrum disorders (ASD) (Egaas et 720 
al., 1995, Piven et al., 1997, Herbert and Kenet, 2007, Frazier and Hardan, 2009, Hardan et al., 721 
2009), attention deficit hyperactivity disorder (Hynd et al., 1991, Roessner et al., 2004, Seidman 722 
et al., 2005), Tourette's syndrome (Plessen et al., 2006), and schizophrenia (Swayze et al., 1990, 723 
Tibbo et al., 1998, Innocenti et al., 2003, Wolf et al., 2008). Further, perturbed dendritic 724 
complexity of layer II/III CPN is observed in multiple neurodevelopmental disorders, including 725 
Rett syndrome (Armstrong et al., 1995, Kishi and Macklis, 2004), ASD (Mukaetova-Ladinska et 726 
al., 2004, Srivastava et al., 2012), and schizophrenia (Broadbelt et al., 2002). Greater 727 
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understanding of molecular regulation of precise temporal and area-specific development of 728 
diverse CPN subpopulations might elucidate perturbations underlying such complex 729 
neurodevelopmental disorders. 730 
 731 
Conclusions 732 
Taken together, our results demonstrate that Cited2 functions differently from previously 733 
described mechanisms to regulate two stages of precise CPN development, acting in neocortical 734 
progenitors to both broadly regulate generation of superficial layer CPN throughout the 735 
neocortex, and in an areally-restricted manner to refine the distinct identity and precise 736 
connectivity of somatosensory CPN. This novel biology of Cited2 adds yet another layer of 737 
complexity to the multi-stage control and regulation of neocortical development.  738 
  34
Author Contributions 739 
R.M.F, J.L.M, and J.D.M. designed the experiments. R.M.F. and J.L.M. performed all of the 740 
experiments, except the DSI/HARDI imaging; E.T. performed imaging for the DSI/HARDI 741 
experiments. S.L.D. provided Cited2 mouse lines and developed specialized genotyping 742 
protocols. R.M.F, J.L.M, and J.D.M. wrote the manuscript, with input from E.T. and S.L.D. 743 
 744 
References: 745 
Armstrong D, Dunn JK, Antalffy B, Trivedi R (1995) Selective dendritic alterations in the cortex 746 
of Rett syndrome. J Neuropathol Exp Neurol 54:195-201. 747 
Azim E, Shnider SJ, Cederquist GY, Sohur US, Macklis JD (2009) Lmo4 and Clim1 748 
progressively delineate cortical projection neuron subtypes during development. Cereb 749 
Cortex 19 Suppl 1:i62-69. 750 
Bamforth SD, Bragança J, Eloranta JJ, Murdoch JN, Marques FI, Kranc KR, Farza H, Henderson 751 
DJ, Hurst HC, Bhattacharya S (2001) Cardiac malformations, adrenal agenesis, neural 752 
crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator. Nat 753 
Genet 29:469-474. 754 
Bamforth SD, Bragança J, Farthing CR, Schneider JE, Broadbent C, Michell AC, Clarke K, 755 
Neubauer S, Norris D, Brown NA, Anderson RH, Bhattacharya S (2004) Cited2 controls 756 
left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat Genet 757 
36:1189-1196. 758 
Barbera JP, Rodriguez TA, Greene ND, Weninger WJ, Simeone A, Copp AJ, Beddington RS, 759 
Dunwoodie S (2002) Folic acid prevents exencephaly in Cited2 deficient mice: Creation 760 
of CITED2 null mice. Hum Mol Genet 11:283-293. 761 
Bedogni F, Hodge RD, Elsen GE, Nelson BR, Daza RA, Beyer RP, Bammler TK, Rubenstein 762 
JL, Hevner RF (2010) Tbr1 regulates regional and laminar identity of postmitotic neurons 763 
in developing neocortex. Proc Natl Acad Sci U S A 107:13129-13134. 764 
Benavides-Piccione R, Hamzei-Sichani F, Ballesteros-Yanez I, DeFelipe J, Yuste R (2006) 765 
Dendritic size of pyramidal neurons differs among mouse cortical regions. Cereb Cortex 766 
16:990-1001. 767 
  35
Betizeau M, Cortay V, Patti D, Pfister S, Gautier E, Bellemin-Menard A, Afanassieff M, 768 
Huissoud C, Douglas RJ, Kennedy H, Dehay C (2013) Precursor diversity and 769 
complexity of lineage relationships in the outer subventricular zone of the primate. 770 
Neuron 80:442-457. 771 
Bhattacharya S, Michels CL, Leung MK, Arany ZP, Kung AL, Livingston DM (1999) 772 
Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by 773 
HIF-1. Genes Dev 13:64-75. 774 
Bishop KM, Rubenstein JL, O'Leary DD (2002) Distinct actions of Emx1, Emx2, and Pax6 in 775 
regulating the specification of areas in the developing neocortex. J Neurosci 22:7627-776 
7638. 777 
Broadbelt K, Byne W, Jones LB (2002) Evidence for a decrease in basilar dendrites of pyramidal 778 
cells in schizophrenic medial prefrontal cortex. Schizophr Res 58:75-81. 779 
Catapano LA, Arnold MW, Perez FA, Macklis JD (2001) Specific neurotrophic factors support 780 
the survival of cortical projection neurons at distinct stages of development. J Neurosci 781 
21:8863-8872. 782 
Cederquist GY, Azim E, Shnider SJ, Padmanabhan H, Macklis JD (2013) Lmo4 establishes 783 
rostral motor cortex projection neuron subtype diversity. J Neurosci 33:6321-6332. 784 
Chen Y, Carlson EC, Chen ZY, Hamik A, Jain MK, Dunwoodie SL, Yang YC (2009) 785 
Conditional deletion of Cited2 results in defective corneal epithelial morphogenesis and 786 
maintenance. Dev Biol 334:243-252. 787 
Chen Y, Doughman Y-Q, Gu S, Jarrell A, Aota S-I, Cvekl A, Watanabe M, Dunwoodie SL, 788 
Johnson RS, Van Heyningen V, Kleinjan DA, Beebe DC, Yang Y-C (2008) Cited2 is 789 
required for the proper formation of the hyaloid vasculature and for lens morphogenesis. 790 
Development 135:2939-2948. 791 
Chou YT, Hsieh CH, Chiou SH, Hsu CF, Kao YR, Lee CC, Chung CH, Wang YH, Hsu HS, 792 
Pang ST, Shieh YS, Wu CW (2012) CITED2 functions as a molecular switch of 793 
cytokine-induced proliferation and quiescence. Cell Death Differ 19:2015-2028. 794 
Cubelos B, Sebastian-Serrano A, Kim S, Moreno-Ortiz C, Redondo JM, Walsh CA, Nieto M 795 
(2008) Cux-2 controls the proliferation of neuronal intermediate precursors of the cortical 796 
subventricular zone. Cereb Cortex 18:1758-1770. 797 
  36
Dehay C, Kennedy H (2007) Cell-cycle control and cortical development. Nat Rev Neurosci 798 
8:438-450. 799 
Deng M, Pan L, Xie X, Gan L (2010) Requirement for Lmo4 in the vestibular morphogenesis of 800 
mouse inner ear. Dev Biol 338:38-49. 801 
Du J, Yang YC (2013) Cited2 in hematopoietic stem cell function. Curr Opin Hematol 20:301-802 
307. 803 
Dye CA, El Shawa H, Huffman KJ (2011) A lifespan analysis of intraneocortical connections 804 
and gene expression in the mouse I. Cereb Cortex 21:1311-1330. 805 
Egaas B, Courchesne E, Saitoh O (1995) Reduced size of corpus callosum in autism. Arch 806 
Neurol 52:794-801. 807 
Fame RM, MacDonald JL, Macklis JD (2011) Development, specification, and diversity of 808 
callosal projection neurons. Trends Neurosci 34:41-50. 809 
Frazier TW, Hardan AY (2009) A meta-analysis of the corpus callosum in autism. Biol 810 
Psychiatry 66:935-941. 811 
Freedman SJ, Sun Z-YJ, Kung AL, France DS, Wagner G, Eck MJ (2003) Structural basis for 812 
negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat Struct Biol 813 
10:504-512. 814 
Glenn DJ, Maurer RA (1999) MRG1 binds to the LIM domain of Lhx2 and may function as a 815 
coactivator to stimulate glycoprotein hormone alpha-subunit gene expression. J Biol 816 
Chem 274:36159-36167. 817 
Goebbels S, Bormuth I, Bode U, Hermanson O, Schwab MH, Nave KA (2006) Genetic targeting 818 
of principal neurons in neocortex and hippocampus of NEX-Cre mice. Genesis 44:611-819 
621. 820 
Gonzalez Y, Zhang Y, Behzadpoor D, Cregan S, Bamforth S, Slack R, Park D (2008) CITED2 821 
Signals through Peroxisome Proliferator-Activated Receptor-  to Regulate Death of 822 
Cortical Neurons after DNA Damage. Journal of Neuroscience 28:5559-5569. 823 
Greig LC, Woodworth MB, Galazo MJ, Padmanabhan H, Macklis JD (2013) Molecular logic of 824 
neocortical projection neuron specification, development and diversity. Nat Rev Neurosci 825 
14:755-769. 826 
Grove EA, Fukuchi-Shimogori T (2003) Generating the cerebral cortical area map. Annu Rev 827 
Neurosci 26:355-380. 828 
  37
Guo H, Hong S, Jin XL, Chen RS, Avasthi PP, Tu YT, Ivanco TL, Li Y (2000) Specificity and 829 
efficiency of Cre-mediated recombination in Emx1-Cre knock-in mice. Biochem Biophys 830 
Res Commun 273:661-665. 831 
Hardan AY, Pabalan M, Gupta N, Bansal R, Melhem NM, Fedorov S, Keshavan MS, Minshew 832 
NJ (2009) Corpus callosum volume in children with autism. Psychiatry Res 174:57-61. 833 
Haubensak W, Attardo A, Denk W, Huttner WB (2004) Neurons arise in the basal 834 
neuroepithelium of the early mammalian telencephalon: a major site of neurogenesis. 835 
Proc Natl Acad Sci U S A 101:3196-3201. 836 
Hayashi S, Tenzen T, McMahon AP (2003) Maternal inheritance of Cre activity in a Sox2Cre 837 
deleter strain. Genesis 37:51-53. 838 
Herbert MR, Kenet T (2007) Brain abnormalities in language disorders and in autism. Pediatr 839 
Clin North Am 54:563-583, vii. 840 
Hevner RF, Shi L, Justice N, Hsueh Y, Sheng M, Smiga S, Bulfone A, Goffinet AM, 841 
Campagnoni AT, Rubenstein JL (2001) Tbr1 regulates differentiation of the preplate and 842 
layer 6. Neuron 29:353-366. 843 
Huang Z, Kawase-Koga Y, Zhang S, Visvader J, Toth M, Walsh CA, Sun T (2009) Transcription 844 
factor Lmo4 defines the shape of functional areas in developing cortices and regulates 845 
sensorimotor control. Dev Biol 327:132-142. 846 
Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D, Lyytinen H (1991) Corpus 847 
callosum morphology in attention deficit-hyperactivity disorder: morphometric analysis 848 
of MRI. J Learn Disabil 24:141-146. 849 
Innocenti GM, Ansermet F, Parnas J (2003) Schizophrenia, neurodevelopment and corpus 850 
callosum. Mol Psychiatry 8:261-274. 851 
Innocenti GM, Price DJ (2005) Exuberance in the development of cortical networks. Nat Rev 852 
Neurosci 6:955-965. 853 
Jin XL, Guo H, Mao C, Atkins N, Wang H, Avasthi PP, Tu YT, Li Y (2000) Emx1-specific 854 
expression of foreign genes using "knock-in" approach. Biochem Biophys Res Commun 855 
270:978-982. 856 
Joshi PS, Molyneaux BJ, Feng L, Xie X, Macklis JD, Gan L (2008) Bhlhb5 regulates the 857 
postmitotic acquisition of area identities in layers II-V of the developing neocortex. 858 
Neuron 60:258-272. 859 
  38
Kashani AH, Qiu Z, Jurata L, Lee SK, Pfaff S, Goebbels S, Nave KA, Ghosh A (2006) Calcium 860 
activation of the LMO4 transcription complex and its role in the patterning of 861 
thalamocortical connections. J Neurosci 26:8398-8408. 862 
Kishi N, Macklis JD (2004) MECP2 is progressively expressed in post-migratory neurons and is 863 
involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 864 
27:306-321. 865 
Kowalczyk T, Pontious A, Englund C, Daza RA, Bedogni F, Hodge R, Attardo A, Bell C, 866 
Huttner WB, Hevner RF (2009) Intermediate neuronal progenitors (basal progenitors) 867 
produce pyramidal-projection neurons for all layers of cerebral cortex. Cereb Cortex 868 
19:2439-2450. 869 
Kranc KR, Bamforth SD, Braganca J, Norbury C, van Lohuizen M, Bhattacharya S (2003) 870 
Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast 871 
proliferation via Ink4a/ARF. Mol Cell Biol 23:7658-7666. 872 
Kranc KR, Schepers H, Rodrigues NP, Bamforth S, Villadsen E, Ferry H, Bouriez-Jones T, 873 
Sigvardsson M, Bhattacharya S, Jacobsen SE, Enver T (2009) Cited2 Is an Essential 874 
Regulator of Adult Hematopoietic Stem Cells. Stem Cell 5:659-665. 875 
Kriegstein A, Noctor S, Martinez-Cerdeno V (2006) Patterns of neural stem and progenitor cell 876 
division may underlie evolutionary cortical expansion. Nat Rev Neurosci 7:883-890. 877 
Lee S, Lee B, Joshi K, Pfaff SL, Lee JW, Lee SK (2008) A regulatory network to segregate the 878 
identity of neuronal subtypes. Dev Cell 14:877-889. 879 
Lomber SG, Payne BR, Rosenquist AC (1994) The spatial relationship between the cerebral 880 
cortex and fiber trajectory through the corpus callosum of the cat. Behav Brain Res 881 
64:25-35. 882 
Lou X, Sun S, Chen W, Zhou Y, Huang Y, Liu X, Shan Y, Wang C (2011) Negative feedback 883 
regulation of NF-kappaB action by CITED2 in the nucleus. J Immunol 186:539-548. 884 
Luo L, O'Leary DD (2005) Axon retraction and degeneration in development and disease. Annu 885 
Rev Neurosci 28:127-156. 886 
Macdonald JL, Verster A, Berndt A, Roskams AJ (2010) MBD2 and MeCP2 regulate distinct 887 
transitions in the stage-specific differentiation of olfactory receptor neurons. Mol Cell 888 
Neurosci 44:55-67. 889 
  39
Maguire CA, Bovenberg MS, Crommentuijn MH, Niers JM, Kerami M, Teng J, Sena-Esteves 890 
M, Badr CE, Tannous BA (2013) Triple bioluminescence imaging for in vivo monitoring 891 
of cellular processes. Mol Ther Nucleic Acids 2:e99. 892 
Martinez-Cerdeno V, Noctor SC, Kriegstein AR (2006) The role of intermediate progenitor cells 893 
in the evolutionary expansion of the cerebral cortex. Cereb Cortex 16 Suppl 1:i152-161. 894 
Michell AC, Braganca J, Broadbent C, Joyce B, Franklyn A, Schneider JE, Bhattacharya S, 895 
Bamforth SD (2010) A novel role for transcription factor Lmo4 in thymus development 896 
through genetic interaction with Cited2. Dev Dyn 239:1988-1994. 897 
Mitchell BD, Macklis JD (2005) Large-scale maintenance of dual projections by callosal and 898 
frontal cortical projection neurons in adult mice. J Comp Neurol 482:17-32. 899 
Miyata T, Kawaguchi A, Saito K, Kawano M, Muto T, Ogawa M (2004) Asymmetric production 900 
of surface-dividing and non-surface-dividing cortical progenitor cells. Development 901 
131:3133-3145. 902 
Mizuno H, Hirano T, Tagawa Y (2007) Evidence for activity-dependent cortical wiring: 903 
formation of interhemispheric connections in neonatal mouse visual cortex requires 904 
projection neuron activity. J Neurosci 27:6760-6770. 905 
Molnar Z, Metin C, Stoykova A, Tarabykin V, Price DJ, Francis F, Meyer G, Dehay C, Kennedy 906 
H (2006) Comparative aspects of cerebral cortical development. Eur J Neurosci 23:921-907 
934. 908 
Molyneaux BJ, Arlotta P, Fame RM, MacDonald JL, MacQuarrie KL, Macklis JD (2009) Novel 909 
Subtype-specific Genes Identify Distinct Subpopulations of Callosal Projection Neurons. 910 
J Neurosci 29. 911 
Motulsky HJ, Brown RE (2006) Detecting outliers when fitting data with nonlinear regression - a 912 
new method based on robust nonlinear regression and the false discovery rate. BMC 913 
Bioinformatics 7:123. 914 
Mukaetova-Ladinska EB, Arnold H, Jaros E, Perry R, Perry E (2004) Depletion of MAP2 915 
expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in 916 
adult autistic individuals. Neuropathol Appl Neurobiol 30:615-623. 917 
Noctor SC, Martinez-Cerdeno V, Ivic L, Kriegstein AR (2004) Cortical neurons arise in 918 
symmetric and asymmetric division zones and migrate through specific phases. Nat 919 
Neurosci 7:136-144. 920 
  40
Noctor SC, Martínez-Cerdeño V, Kriegstein AR (2008) Distinct behaviors of neural stem and 921 
progenitor cells underlie cortical neurogenesis. J Comp Neurol 508:28-44. 922 
O'Leary DD, Chou SJ, Sahara S (2007) Area patterning of the mammalian cortex. Neuron 923 
56:252-269. 924 
Olivares R, Montiel J, Aboitiz F (2001) Species differences and similarities in the fine structure 925 
of the mammalian corpus callosum. Brain Behav Evol 57:98-105. 926 
Paul LK, Brown WS, Adolphs R, Tyszka JM, Richards LJ, Mukherjee P, Sherr EH (2007) 927 
Agenesis of the corpus callosum: genetic, developmental and functional aspects of 928 
connectivity. Nat Rev Neurosci 8:287-299. 929 
Pinto L, Drechsel D, Schmid M-T, Ninkovic J, Irmler M, Brill MS, Restani L, Gianfranceschi L, 930 
Cerri C, Weber SN, Tarabykin V, Baer K, Guillemot F, Beckers J, Zecevic N, Dehay C, 931 
Caleo M, Schorle H, Götz M (2009) AP2γ regulates basal progenitor fate in a region- and 932 
layer-specific manner in the developing cortex. Nat Neurosci 12:1229-1237. 933 
Piven J, Bailey J, Ranson BJ, Arndt S (1997) An MRI study of the corpus callosum in autism. 934 
Am J Psychiatry 154:1051-1056. 935 
Plessen KJ, Gruner R, Lundervold A, Hirsch JG, Xu D, Bansal R, Hammar A, Lundervold AJ, 936 
Wentzel-Larsen T, Lie SA, Gass A, Peterson BS, Hugdahl K (2006) Reduced white 937 
matter connectivity in the corpus callosum of children with Tourette syndrome. J Child 938 
Psychol Psychiatry 47:1013-1022. 939 
Polleux F, Dehay C, Goffinet A, Kennedy H (2001) Pre- and post-mitotic events contribute to 940 
the progressive acquisition of area-specific connectional fate in the neocortex. Cereb 941 
Cortex 11:1027-1039. 942 
Pontious A, Kowalczyk T, Englund C, Hevner RF (2008) Role of intermediate progenitor cells 943 
in cerebral cortex development. Dev Neurosci 30:24-32. 944 
Preis JI, Wise N, Solloway MJ, Harvey RP, Sparrow DB, Dunwoodie SL (2006) Generation of 945 
conditional Cited2 null alleles. Genesis 44:579-583. 946 
Rash BG, Grove EA (2006) Area and layer patterning in the developing cerebral cortex. Curr 947 
Opin Neurobiol 16:25-34. 948 
Roessner V, Banaschewski T, Uebel H, Becker A, Rothenberger A (2004) Neuronal network 949 
models of ADHD -- lateralization with respect to interhemispheric connectivity 950 
reconsidered. Eur Child Adolesc Psychiatry 13 Suppl 1:I71-79. 951 
  41
Rosen GD, Azoulay NG, Griffin EG, Newbury A, Koganti L, Fujisaki N, Takahashi E, Grant 952 
PE, Truong DT, Fitch RH, Lu L, Williams RW (2013) Bilateral subcortical heterotopia 953 
with partial callosal agenesis in a mouse mutant. Cereb Cortex 23:859-872. 954 
Schuurmans C, Armant O, Nieto M, Stenman JM, Britz O, Klenin N, Brown C, Langevin LM, 955 
Seibt J, Tang H, Cunningham JM, Dyck R, Walsh C, Campbell K, Polleux F, Guillemot 956 
F (2004) Sequential phases of cortical specification involve Neurogenin-dependent and -957 
independent pathways. Embo J 23:2892-2902. 958 
Seidman LJ, Valera EM, Makris N (2005) Structural brain imaging of attention-959 
deficit/hyperactivity disorder. Biol Psychiatry 57:1263-1272. 960 
Sessa A, Mao CA, Hadjantonakis AK, Klein WH, Broccoli V (2008) Tbr2 directs conversion of 961 
radial glia into basal precursors and guides neuronal amplification by indirect 962 
neurogenesis in the developing neocortex. Neuron 60:56-69. 963 
Shetty RS, Bose SC, Nickell MD, McIntyre JC, Hardin DH, Harris AM, McClintock TS (2005) 964 
Transcriptional changes during neuronal death and replacement in the olfactory 965 
epithelium. Mol Cell Neurosci 30:583-600. 966 
Sholl DA (1953) Dendritic organization in the neurons of the visual and motor cortices of the 967 
cat. J Anat 87:387-406. 968 
Song JW, Mitchell PD, Kolasinski J, Ellen Grant P, Galaburda AM, Takahashi E (2015) 969 
Asymmetry of White Matter Pathways in Developing Human Brains. Cereb Cortex 970 
25:2883-2893. 971 
Srivastava DP, Woolfrey KM, Jones KA, Anderson CT, Smith KR, Russell TA, Lee H, 972 
Yasvoina MV, Wokosin DL, Ozdinler PH, Shepherd GM, Penzes P (2012) An autism-973 
associated variant of Epac2 reveals a role for Ras/Epac2 signaling in controlling basal 974 
dendrite maintenance in mice. PLoS Biol 10:e1001350. 975 
Suarez R, Fenlon LR, Marek R, Avitan L, Sah P, Goodhill GJ, Richards LJ (2014) Balanced 976 
interhemispheric cortical activity is required for correct targeting of the corpus callosum. 977 
Neuron 82:1289-1298. 978 
Swayze VW, 2nd, Andreasen NC, Ehrhardt JC, Yuh WT, Alliger RJ, Cohen GA (1990) 979 
Developmental abnormalities of the corpus callosum in schizophrenia. Arch Neurol 980 
47:805-808. 981 
  42
Takahashi E, Dai G, Wang R, Ohki K, Rosen GD, Galaburda AM, Grant PE, Wedeen VJ (2010) 982 
Development of cerebral fiber pathways in cats revealed by diffusion spectrum imaging. 983 
NeuroImage 49:1231-1240. 984 
Tibbo P, Nopoulos P, Arndt S, Andreasen NC (1998) Corpus callosum shape and size in male 985 
patients with schizophrenia. Biol Psychiatry 44:405-412. 986 
Tuch DS, Reese TG, Wiegell MR, Wedeen VJ (2003) Diffusion MRI of complex neural 987 
architecture. Neuron 40:885-895. 988 
Tuoc TC, Narayanan R, Stoykova A (2013) BAF chromatin remodeling complex: cortical size 989 
regulation and beyond. Cell Cycle 12:2953-2959. 990 
Wang C, Zhang L, Zhou Y, Zhou J, Yang X, Duan S, Xiong Z, Ding Y (2007) Activity-991 
Dependent Development of Callosal Projections in the Somatosensory Cortex. Journal of 992 
Neuroscience 27:11334-11342. 993 
Weninger WJ, Lopes Floro K, Bennett MB, Withington SL, Preis JI, Barbera JP, Mohun TJ, 994 
Dunwoodie SL (2005) Cited2 is required both for heart morphogenesis and establishment 995 
of the left-right axis in mouse development. Development 132:1337-1348. 996 
Wilson CJ (1987) Morphology and synaptic connections of crossed corticostriatal neurons in the 997 
rat. J Comp Neurol 263:567-580. 998 
Withington SL, Scott AN, Saunders DN, Lopes Floro K, Preis JI, Michalicek J, Maclean K, 999 
Sparrow DB, Barbera JP, Dunwoodie SL (2006) Loss of Cited2 affects trophoblast 1000 
formation and vascularization of the mouse placenta. Dev Biol 294:67-82. 1001 
Wolf RC, Hose A, Frasch K, Walter H, Vasic N (2008) Volumetric abnormalities associated 1002 
with cognitive deficits in patients with schizophrenia. Eur Psychiatry 23:541-548. 1003 
Xu B, Qu X, Gu S, Doughman YQ, Watanabe M, Dunwoodie SL, Yang YC (2008) Cited2 is 1004 
required for fetal lung maturation. Dev Biol 317:95-105. 1005 
Zhou J, Wen Y, She L, Sui YN, Liu L, Richards LJ, Poo MM (2013) Axon position within the 1006 
corpus callosum determines contralateral cortical projection. Proc Natl Acad Sci U S A 1007 
110:E2714-2723. 1008 
 1009 
 1010 
 1011 
  43
Figure Legends: 1012 
 1013 
Figure 1: Cited2 is expressed broadly by CPN progenitors at E15.5, with expression refining to 1014 
CPN of somatosensory cortex by P3  1015 
(A) Cited2 is highly expressed by callosal projection neurons (CPN; red) relative to corticospinal 1016 
motor neurons (CSMN; blue) at critical times during development, as detected by microarray 1017 
analysis of FACS-purified CPN and CSMN. Error bars denote SEM (Molyneaux et al., 2009). (B) 1018 
Western blot analysis showing that CITED2 protein is highly expressed as early as E15.5 in the 1019 
neocortex, with expression decreasing postnatally, relative to a β-actin loading control. (C) 1020 
Expression of Cited2 is largely restricted to subpallial progenitors at E13.5, but (D) Cited2 is highly 1021 
expressed in the cortical subventricular zone (SVZ) at E15.5, the peak of superficial layer CPN birth, 1022 
with (E-F) expression maintained in layers II/III, and V postnatally. (G) Embryonically, Cited2 is 1023 
expressed uniformly across the neocortex, detected across the SVZ at E18.5 (arrowheads), and across 1024 
the cortical plate (CP). (H) In the first days postnatally, however, its expression refines and becomes 1025 
restricted to somatosensory cortex (arrows) by P3. (I) At E15.5, Cited2 is highly expressed in the 1026 
subventricular zone (SVZ), extending into the intermediate zone (IZ). (J) Cited2  (blue) is largely 1027 
excluded from PAX6+ (green) radial glial progenitors of the ventricular zone (VZ), but is highly 1028 
expressed by TBR2+ (red) intermediate progenitor cells (IPCs) of the SVZ. (K) Cited2 is largely 1029 
excluded from the highly proliferative, Ki67+ (green) VZ and apical mitotic cells, as indicated by 1030 
pH3 (red), but is expressed by basally-proliferating IPCs of the SVZ and IZ, VZ = ventricular zone; 1031 
SVZ = subventricular zone; IZ = intermediate zone; CP = cortical plate. Scale bars in (C-F) = 1032 
500μm; (G, H, I) = 1mm (C’,-H’, J-K) = 100μm; (I’)=200μm. Dotted lines in J and K indicate 1033 
apical, ventricular surface. 1034 
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 1035 
Figure 2: Loss of Cited2 function results in specific reduction of TBR2+ IPCs in E15.5 1036 
neocortex 1037 
(A-A”) At E15.5, the peak of Cited2 expression, there is no change in the overall number of 1038 
(PAX6+) radial glial progenitors in Cited2;Emx1-Cre conditional knockout neocortex (cKO) 1039 
compared to control littermates (WT). (B-B’’) There is, however, a significant reduction in the 1040 
number of TBR2+ intermediate progenitor cells (IPCs), which largely give rise to superficial layer 1041 
CPN at this stage of development. Reduction in TBR2+ IPCs might result from (C-C’’) reduced 1042 
proliferation of IPCs, as indicated by proliferating cell nuclear antigen (PCNA, red) and TBR2 1043 
(green) double positivity (N = 11 WT, 6 cKO for A-C); (D-D’’) specific reduction in basal cell 1044 
divisions, as indicated by position of pH3-positive mitotic cells (N = 10 WT, 5 cKO); and/or (E) 1045 
increased cell death, as indicated by expression of activated caspase-3+ (aC3). There is increased 1046 
apoptotic cell death in Cited2 cKO neocortex, both within the progenitor population and post-1047 
mitotically (N = 11 WT, 6 cKO). (F-F’’) To directly investigate whether Cited2 cell-autonomously 1048 
regulates proliferation of IPCs, we electroporated Cre recombinase and GFP into VZ progenitors 1049 
of Cited2 fl/fl and Cited2 fl/wt littermates at E14.5, to excise Cited2 in a small subpopulation of 1050 
neocortical progenitors. We employed a BrdU pulse at E15.5, and immunocytochemistry for 1051 
Ki67 at E16.5 to identify progenitors that continued to proliferate. There is a significant 1052 
reduction in the number of Cited2-null (Cited2 fl/fl; Cre+) progenitors that incorporate BrdU at 1053 
E15.5, or express Ki67+ at E16.5, demonstrating that Cited2-null IPCs are less likely to re-enter 1054 
the cell cycle than their heterozygous counterparts. There is no change in the number of aC3+ 1055 
cells in the Cited2-null progenitors at E16.5. (N = 4 Cited2 fl/wt; 5 Cited2 fl/fl). Scale bars = 100μm. 1056 
Error bars denote SEM. * p<0.05; ** p<0.001 (Student’s t-test) 1057 
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 1058 
Figure 3: Loss of Cited2 function results in reduced superficial layer thickness and total 1059 
neocortical length at P3   1060 
(A) At P6, Cited2 cKO neocortex is smaller than in WT littermate controls, but both CPN (SATB2+) 1061 
and CSMN (CTIP2+) are present and appropriately positioned. (B) Anterograde labeling with DiI 1062 
and (C) retrograde labeling with CTB demonstrate that CPN are present and are targeting the 1063 
contralateral hemisphere in Cited2 cKO neocortex. However, both the distribution of retrogradely-1064 
labeled CPN (C), and (D) CUX1 (red, superficial layers) and CTIP2 (green, deep layers) 1065 
immunocytochemistry, indicate that superficial layers are reduced in thickness in the Cited2 cKO 1066 
neocortex, while deep layers are not changed in thickness (N = 4-5 per genotype for A-D). (E) 1067 
Quantitative analysis of neocortical layer thickness at P3 reveals that superficial layers (II-IV; 1068 
LMO4, red) are significantly reduced in thickness in motor, somatosensory, and visual neocortical 1069 
areas of P3 Cited2 cKO, in comparison to control littermates. There is no change in deep layer 1070 
thickness (V-VI; CTIP2, green) in any region (N = 8 WT, 4 cKO). (F) Cited2 cKO cortex is visibly 1071 
smaller than in control littermates at P3, both in wholemount view and in sagittal sections. (G) There 1072 
is a significant reduction in total neocortical surface rostrocaudal length of approximately 10%, as 1073 
measured on four sagittal sections across the medio-lateral axis (N = 8 WT, 4 cKO). Scale bar in A = 1074 
1mm, B = 50μm. Error bars denote SEM. * p < 0.05; ** p < 0.001 (Student’s t-test) 1075 
 1076 
Figure 4: Neocortical surface length reduction is restricted to layers II/III of somatosensory 1077 
cortex in P3 Cited2 cKO neocortex 1078 
(A-C) Analysis of three broad neocortical areas identified by LMO4 expression at P3 indicates a 1079 
highly specific and substantial reduction (~30%) in rostro-caudal surface length of the somatosensory 1080 
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area (blue) in Cited2 cKO neocortex, entirely accounting for the total cortical surface length 1081 
reduction (N = 8 WT, 4 cKO). (D-G) Reduced somatosensory cortex length (black arrowheads) was 1082 
confirmed via expression of multiple genes either excluded from superficial layers of somatosensory 1083 
cortex (D,E; Cadh8, EphA7), or specifically expressed in somatosensory cortex (F; ephrinA5). 1084 
Measurements of acallosal layer IV somatosensory cortex (black arrows), in contrast (F,G; ephrinA5, 1085 
Rorβ), reveals that there is no significant difference in non-CPN somatosensory cortex length in 1086 
Cited2 cKO compared to WT (N = 8 WT, 4 cKO). (H-H’’’) In P3 Cited2 WT neocortex, molecular 1087 
markers of layer IV (green, RORβ; bracket) and somatosensory cortex in layers II/III (red, Bhlhb5; 1088 
white line) align at the motor / somatosensory border, shown in sagittal view (rostral to left). (I-I’’’) 1089 
In P3 Cited2 cKO neocortex, in contrast, the boundary of layer II/III expression of Bhlhb5 (white 1090 
line, with additional low-level expression indicated by dashed line) is located caudal to layer IV 1091 
RORβ expression (bracket), resulting in a misalignment of molecular areal boundaries between CPN 1092 
of layer II/III and acallosal layer IV (schematized in H’’’ and I’’’) (N = 4-5 per genotype). Scale bar 1093 
in D-G = 500μm, H-I = 200μm. Error bars denote SEM. * p < 0.05; ** p < 0.001 (Student’s t-test) 1094 
 1095 
Figure 5: Additional loss of Lmo4 function does not alter Cited2 cKO neocortical thickness, but does 1096 
reestablish layer II/III somatosensory neocortical length at the expense of motor cortex.  1097 
(A-C) Additional loss of Lmo4 function in Cited2 null neocortex (Cited2fl/fl;Lmo4fl/fl;Emx1Cre/+) 1098 
does not alter the reduced reduction in superficial layer thickness of Cited2 null motor or visual 1099 
cortex, but does increase superficial layer thickness in somatosensory cortex. Additional loss of 1100 
Lmo4 function does not alter the overall reduction in total neocortical length (data not shown). 1101 
(D-G) Additional loss of Lmo4 function does, however, reestablish layer II/III somatosensory 1102 
neocortical length (as measured by Bhlhb5 expression) to normal control length, at the expense 1103 
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of layer II/III motor cortex. (H) Length of motor (rostral to Bhlhb5 layer II/III expression), 1104 
somatosensory (Bhlhb5 layer II/III positive), and visual (caudal to layer II/III Bhlhb5 expression) 1105 
cortical areas was measured in control (Emx1-cre negative), Lmo4 cKO 1106 
(Cited2+/+;Lmo4fl/fl;Emx1Cre/+), Cited2 cKO (Cited2fl/fl;Lmo4+/+;Emx1Cre/+), and double cKO 1107 
(Cited2fl/fl;Lmo4fl/fl;Emx1Cre/+) littermates. (I-L) In the context of the shortened neocortical 1108 
surface length in Cited2 cKO mice, additional loss of Lmo4 function reestablishes the length of 1109 
the somatosensory area boundary, at the expense of motor cortex length. Loss of Lmo4 function 1110 
has no effect on the overall reduced neocortical length or layer II/III thickness of Cited2 cKO 1111 
neocortex, in contrast. Scale bars in (C) = 100μm; (D-G) 1mm. For each neocortical area, data 1112 
were analyzed by a one-way ANOVA with Tukey post-test. For all experiments, N = 14 controls, 1113 
7 Lmo4 cKO, 7 Cited2 cKO, and 8 double cKO. Error bars denote SEM. * p < 0.05, **p < 0.001, 1114 
***p < 0.0001. 1115 
 1116 
Figure 6: Excision of Cited2 post-mitotically via NEX-Cre does not alter neocortical laminar 1117 
thickness or neocortical area lengths. 1118 
(A) NEX-Cre mediated post-mitotic excision of Cited2 does not visibly alter brain morphology 1119 
or neocortical laminar development at P6 (as indicated by DAPI nuclear staining), and (B) there 1120 
is no significant difference in P3 neocortical length between Cited2; NEX-Cre cKO mice and 1121 
control littermates. Further, (C-C’’) there is no change in the overall neocortical laminar thickness 1122 
of superficial or deep layers in P3 Cited2; NEX-cre cKO neocortex, nor (D-E) is there a change in the 1123 
length of motor, somatosensory, or visual neocortical area lengths in Cited2; NEX-Cre cKO 1124 
neocortex. For all experiments, N = 4 WT, 4 cKO. Scale bar in A = 1 mm, C = 100 μm. Error bars 1125 
denote SEM. 1126 
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 1127 
Figure 7: Loss of Cited2 function results in aberrant dendritic complexity of superficial layer 1128 
somatosensory CPN   1129 
(A-A’) Neuronal soma size (NeuN area) is not affected by loss of Cited2. Increased neuronal density 1130 
is evident here, consistent with the modest, but significant, increase in cell density in layer II/III of 1131 
somatosensory cortex (23% increase, p=0.01) quantified at P6 (see Results text). N = 3 WT, 3 1132 
cKO. (B-D) Dendritic complexity of layer II/III pyramidal neurons (primarily CPN) was analyzed at 1133 
P22 by Golgi staining and Sholl analysis in Cited2;Emx1-cre cKO neocortex, in comparison to 1134 
control littermates. There is no significant difference in dendritic complexity of layer II/III CPN in 1135 
(B-B') motor cortex or (D-D’) visual cortex of Cited2; Emx1-cre cKO mice, compared to littermate 1136 
controls. (C-C’) There is, however, a significant increase in dendritic complexity of layer II/III CPN 1137 
in somatosensory cortex of Cited2;Emx1-cre cKO (two-way ANOVA p < 0.0001). (E) CPN of 1138 
motor cortex are more complex than CPN of somatosensory or visual cortex (two-way ANOVA p < 1139 
0.0001). (F) In Cited2; Emx1-Cre cKO mice, dendritic complexity of somatosensory CPN is not 1140 
significantly different from CPN of motor cortex (two-way ANOVA p = 0.16), suggesting that 1141 
somatosensory CPN might be partially “motorized” in the absence of Cited2 function. (G-I) 1142 
Dendritic complexity of layer II/III CPN was analyzed at P22 by Golgi staining and Sholl analysis in 1143 
Cited2;NEX-Cre conditional knockout neocortex, in comparison to control littermates. Following 1144 
this post-mitotic loss of Cited2 function, there is no change in dendritic complexity of superficial 1145 
layer pyramidal neurons in any of the primary areas examined (motor, somatosensory, or visual). 1146 
Scale bars = 50μm. * p < 0.05, ** p < 0.01, *** p < 0.001, Bonferroni post-test in B, C, D, E, F, G). 1147 
(B-E) Motor: N = 17 WT, 12 cKO; Somatosensory: N = 27 WT, 14 cKO; Visual: N = 18 WT, 9 1148 
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cKO. (G-I) Motor: N = 38 WT, 34 cKO; Somatosensory: N = 37 WT, 20 cKO; Visual: N = 34 WT, 1149 
19 cKO. 1150 
 1151 
Figure 8: Interhemispheric CPN axonal connectivity is disrupted in adult Cited2 cKO 1152 
neocortex 1153 
(A-B) HARDI tractography analysis of interhemispheric connections demonstrates a significant 1154 
reduction in the size of the corpus callosum (CC), and in the number of callosal fibers in juvenile/ 1155 
young adult (9wks) Cited2; Emx1 cre cKO neocortex, compared to littermate controls, particularly 1156 
within the mid-CC (corresponding to somatosensory cortex). Reconstructed pathways are 1157 
superimposed on the mean diffusion-weighted magnetic resonance image of the brain. Pathways 1158 
running between right and left are red; dorsal and ventral are green; and anterior and posterior 1159 
are blue. The images do not include anterior commissure or olfactory bulb fibers; these were 1160 
removed a priori to focus on the CC. Images in A’ and B’ similarly exclude hippocampal 1161 
commissure fibers. N = 2 WT, 2 cKO. (C-D) Staining for myelin basic protein in sagittal 1162 
sections of Cited2 WT and cKO brains followed by measurement of midsagittal CC area (D) 1163 
identifies a reduction in CC area in Cited2 cKO brains, but demonstrates the structural integrity 1164 
of the CC throughout all areas. N = 3 WT, 4 cKO. (E-K) To investigate precision of callosal 1165 
projections in the absence of Cited2 function, a focal injection of the anterograde tracer AAV-1166 
GFP was made in somatosensory (extending into motor) neocortex at P6, and contralateral 1167 
callosal projections were analyzed at 6 weeks of age. In contrast to the precise homotopic 1168 
projections observed in Cited2 WTs (G), callosal projections in Cited2 cKO somatosensory 1169 
neocortex are diffuse (J). (K) Relative GFP fluorescence intensity was measured in matched 1170 
sagittal sections of the left, injected neocortical hemisphere, and in the same region in the 1171 
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contralateral, projection hemisphere, demonstrating consistent caudal spread of callosal 1172 
projections in Cited2 cKO neocortex. N = 3 WT, 3 cKO. ANOVA analysis finds no change in 1173 
the anterior tail (-1400μm to -800μm) or center (-700μm to 700μm) regions, but the posterior tail 1174 
(800μm to 1400μm) of the cKO distribution is significantly different than that of the WT (p < 1175 
0.0001). Error bars denote SEM. * p < 0.05, (Student’s t-test) in C. * p < 0.001 (Bonferroni-post 1176 
test) in K. Scale bar in A-B = 1.5mm, C,D, F,G, I,J = 1mm,  G’,J’ = 500μm. 1177 








